Why the study?
Are hereditary deficiencies in physiological anticoagulants and activated protein C resistance present in patients with childhood stroke?
Are hereditary deficiencies in physiological anticoagulants and activated protein C resistance present in patients with childhood stroke?
Answers are grounded in this paper and cite their sources.
Hereditary deficiencies of physiological anticoagulants were not identified in this cohort of childhood stroke, emphasizing the need for careful diagnostic criteria to avoid inappropriate treatment.
Immunological and functional protein S, protein C and antithrombin III levels and anticoagulant responses to activated protein C were measured in 24 patients with stroke in childhood. No hereditary deficiencies were found. The protein S levels in healthy controls of younger age did not differ from the adult levels. For optimal screening of protein S deficiency, measurements using functional as well as immunological assays are recommended. Appropriate criteria for the diagnosis of the deficiencies must be carefully applied if unnecessary anxiety and inappropriate treatment of children are to be avoided.
No takes yet. Share an insight, caveat, or question.
Riikonen et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: